Compare Stocks → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CMPIBATS:MIG Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCMPICheckmate Pharmaceuticals$10.50$10.46$2.00▼$10.50$231.40M-4.81142,261 shsN/AMIGVanEck Moodys Analytics IG Corporate Bond ETF$21.01-0.1%$20.92$0.00▼$0.00$12.61M0.23N/A103 shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCMPICheckmate Pharmaceuticals0.00%0.00%0.00%0.00%0.00%MIGVanEck Moodys Analytics IG Corporate Bond ETF-0.23%+0.43%+1.79%+0.16%+1.06%I’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCMPICheckmate PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AMIGVanEck Moodys Analytics IG Corporate Bond ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCMPICheckmate PharmaceuticalsN/AN/AN/AN/AMIGVanEck Moodys Analytics IG Corporate Bond ETF0.00N/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCMPICheckmate PharmaceuticalsN/AN/AN/AN/A$2.50 per shareN/AMIGVanEck Moodys Analytics IG Corporate Bond ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCMPICheckmate Pharmaceuticals-$61.40M-$2.92N/AN/AN/AN/A-83.92%-74.99%N/AMIGVanEck Moodys Analytics IG Corporate Bond ETFN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCMPICheckmate PharmaceuticalsN/AN/AN/AN/AN/AMIGVanEck Moodys Analytics IG Corporate Bond ETFN/AN/AN/AN/AN/ALatest MIG, MIG1, EJFI, and CMPI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2024MIGVanEck Moodys Analytics IG Corporate Bond ETF$0.08734/1/20244/2/20244/5/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCMPICheckmate PharmaceuticalsN/A5.205.20MIGVanEck Moodys Analytics IG Corporate Bond ETFN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCMPICheckmate Pharmaceuticals74.56%MIGVanEck Moodys Analytics IG Corporate Bond ETFN/AInsider OwnershipCompanyInsider OwnershipCMPICheckmate Pharmaceuticals62.60%MIGVanEck Moodys Analytics IG Corporate Bond ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCMPICheckmate Pharmaceuticals2822.04 million8.24 millionNot OptionableMIGVanEck Moodys Analytics IG Corporate Bond ETFN/A600,000N/ANot OptionableMIG, MIG1, EJFI, and CMPI HeadlinesRecent News About These CompaniesMay 2, 2024 | msn.comVanEck Vectors Moody’s Analytics BBB Corporate Bond ETF declares monthly distribution of $0.0846March 8, 2024 | etftrends.comWhy This Corporate Bond ETF Merits Attention NowJanuary 16, 2024 | seekingalpha.comCorporate Credit Outlook 2024: High Tide For Yield?January 6, 2024 | benzinga.comVanEck Moody's Analytics IG Corporate Bond ETF (BATS:MIG), Quotes and News SummaryDecember 22, 2023 | finance.yahoo.comThere’s Value to Be Had in BondsDecember 4, 2023 | msn.comVanEck Vectors Moody’s Analytics IG Corporate Bond ETF declares monthly distribution of $0.0788November 30, 2023 | investing.comKB KBSTAR US Short-term IG Corporate Bond ETF (437350)November 6, 2023 | finance.yahoo.comVanEck Moody's Analytics BBB Corporate Bond ETF (MBBB)November 3, 2023 | msn.comVanEck Vectors Moody’s Analytics BBB Corporate Bond ETF declares monthly distribution of $0.0816November 3, 2023 | msn.comVanEck Vectors Moody’s Analytics IG Corporate Bond ETF declares monthly distribution of $0.0802September 4, 2023 | msn.comVanEck Vectors Moody’s Analytics BBB Corporate Bond ETF declares monthly distribution of $0.0810August 4, 2023 | msn.comVanEck Vectors Moody’s Analytics IG Corporate Bond ETF declares monthly distribution of $0.0815Media Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months5 High-Yielding Oversold Stocks with Bullish RatingsApril 26, 2024 9:06 AMView 5 High-Yielding Oversold Stocks with Bullish RatingsBounce Alert: 3 Large Caps With RSIs Too Good To IgnoreMay 10, 2024 11:45 AMView Bounce Alert: 3 Large Caps With RSIs Too Good To IgnoreAll HeadlinesCompany DescriptionsCheckmate PharmaceuticalsNASDAQ:CMPICheckmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.VanEck Moodys Analytics IG Corporate Bond ETFBATS:MIGThe VanEck Moody's Analytics IG Corporate Bond ETF (MIG) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a market-value-weighted index of investment grade corporate bonds issued in the US domestic market. MIG was launched on Dec 1, 2020 and is managed by VanEck. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
